Szívelégtelenség: vizsgálatok itt: Olaszország
103 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleEfficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- Bergamo, Bologna, Florence, Genoa, Milan, Padova, Rome, Turin
- Életkor
- 29 nap to 17 év
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00 - 2. fázisNot yet taking people in OlaszországA Study of Bimagrumab in Participants With HFpEF
- Where
- Caserta, Torino
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07920887 · EU 2026-527983-34-00 - No phaseTaking peopleTrial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Where
- Turin
- Életkor
- 18 év and over
- People
- 850 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT06526195 - No phaseTaking peopleProduct Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Where
- Ancona, Bari, Bergamo, Bologna, Brescia, Castrovillari, Cotignola, Lecce, Milan, Monza, Pisa, Taranto, Udine
- People
- 20 000 worldwide
- Run by
- Medtronic
See details and how to joinNCT00271180 - No phaseTaking peopleHeart Failure and Aortic Stenosis Transcriptome
- Where
- Milan, San Donato Milanese
- Életkor
- 40 év to 75 év
- People
- 500
- Run by
- IRCCS Policlinico S. Donato
See details and how to joinNCT03268135 - 3. fázisTaking peopleStudy With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Where
- Arzignano, Bergamo, Brescia, Ferrara, Milan, Perugia, Rimini, Rome, Sesto San Giovanni
- Életkor
- 18 év to 85 év
- People
- 1800 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT06736574 · EU 2024-519219-32-00 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Bari, Bergamo, Brescia, Cortona AR, Foggia, Forlì, Milan, Naples, Parma, Pavia, Rimini, Rivoli, Roma, Sassari
- Életkor
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - No phaseNot yet taking people in OlaszországMetabolic Changes in Heart Failure Patients Treated With Vericiguat
- Where
- Potenza
- Életkor
- 18 év and over
- People
- 30
- Run by
- University of Salerno
See details and how to joinNCT07901270 - 3. fázisTaking peopleA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Bergamo, Foggia, Genoa, Naples, Pavia, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 6712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00 - 3. fázisTaking peopleA Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Bergamo, Naples, Pavia, Pisa, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 4200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Bari, Bergamo, Brescia, Cortona, Foggia, Forli', Milan, Naples, Parma, Pavia, Rimini, Rivoli, Rome, Rozzano, Sassari
- Életkor
- 18 év and over
- People
- 2787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - 3. fázisTaking peopleA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Bergamo, Bologna, Genoa, Milan, Naples, Padova, Rome, Turin
- Életkor
- Up to 18 év
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00 - No phaseTaking peopleBIO|STREAM.CSP Study
- Where
- Bergamo, Brindisi, Milan, Novara, Piove di Sacco, Roma, Taranto
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Biotronik SE & Co. KG
See details and how to joinNCT07393009 - 3. fázisTaking peoplePhase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Where
- Alexandria, Bari, Bergamo, Brescia, Chiavari, Ferrara, Foggia, Milan, Monza, Naples, Novara, Orbassano, Palermo, Pavia, Potenza, Rome, Rozzano, Siena, Turin, Udine
- Életkor
- 40 év and over
- People
- 11 300 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00 - 3. fázisTaking peopleCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Ancona - Torrette, Bologna, Bolzano, Brescia, Cona, Florence, Ivrea, Lecco, Messina, Milan, Naples, Orbassano, Palermo, Pavia, Perugia, Pisa, Roma, Rome, San Donato Milanese, Trieste
- Életkor
- 18 év and over
- People
- 1280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811 - No phaseTaking peopleCytOSorb TreatMent Of Critically Ill PatientS Registry
- Where
- Roma, San Giovanni Rotondo
- People
- 3000 worldwide
- Run by
- CytoSorbents, Inc
See details and how to joinNCT05146336 - No phaseTaking peopleDrug Management in Heart Failure
- Where
- Rome
- Életkor
- 18 év and over
- People
- 450
- Run by
- IRCCS San Raffaele Roma
See details and how to joinNCT06915584 - No phaseTaking peopleThe Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- Where
- Roma
- Életkor
- 18 év and over
- People
- 754 worldwide
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT05427370 - No phaseTaking peopleEstimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI)
- Where
- San Donato Milanese
- Életkor
- 16 év and over
- People
- 600
- Run by
- IRCCS Policlinico S. Donato
See details and how to joinNCT07095634 - 4. fázisTaking peoplePharmacological Optimization in Prevention in Heart Failure: A Sex-gap?
- Where
- Ancona, Cecina, Ferrara, Florence, Milan, Pisa, Ravenna, Reggio Emilia, Roma, San Donato Milanese
- Életkor
- 18 év to 85 év
- People
- 368
- Run by
- IRCCS Policlinico S. Donato
See details and how to joinNCT07295522 - 3. fázisTaking peopleA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Bergamo, Bologna, Genoa, Milan, Naples, Padova, Rome, Turin
- Életkor
- 6 hónap to 17 év
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00 - 3. fázisTaking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Acquaviva delle Fonti, Bari, Bergamo, Brescia, Catania, Catanzaro, Cona, Cortona, Florence, Milan, Novara, Pavia, San Giovanni Rotondo
- Életkor
- 18 év to 130 év
- People
- 3850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - No phaseTaking peopleFluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
- Where
- Ancona, Bergamo, Milan
- Életkor
- 22 év and over
- People
- 400 worldwide
- Run by
- Reprieve Cardiovascular, Inc
See details and how to joinNCT06898515 - No phaseTaking peopleArtificial Voice Analysis and Telemonitoring for Heart Failure. A Feasibility Study
- Where
- Milan
- Életkor
- 18 év and over
- People
- 60
- Run by
- Niguarda Hospital
See details and how to joinNCT07664748 - No phaseTaking peopleA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462